ASSET PURCHASE AGREEMENT by and between NAUTILUS NEUROSCIENCES, INC., as Seller and DEPOMED, INC., as Purchaser Dated as of December 17, 2013Asset Purchase Agreement • March 17th, 2014 • Depomed Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 17th, 2014 Company Industry JurisdictionThis Asset Purchase Agreement is made as of December 17, 2013, by and between Nautilus Neurosciences, Inc., a Delaware corporation (“Seller”), and Depomed, Inc., a California corporation (“Purchaser”). Seller and Purchaser are sometimes referred to herein collectively as the “Parties” and individually as a “Party.”
ROYALTY PURCHASE AND SALE AGREEMENT dated as of October 18, 2013 between DEPOMED, INC., DEPO DR SUB, LLC, as Seller, and PDL BIOPHARMA, INC., as PurchaserRoyalty Purchase and Sale Agreement • March 17th, 2014 • Depomed Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 17th, 2014 Company Industry JurisdictionThis ROYALTY PURCHASE AND SALE AGREEMENT (this “Royalty Purchase and Sale Agreement”) dated as of October 18, 2013 is among Depomed, Inc., a California corporation (“Depomed”), Depo DR Sub, LLC, a Delaware limited liability company (the “Seller,” and together with Depomed, the “Selling Parties”) and PDL BioPharma, Inc., a Delaware corporation (the “Purchaser”).